These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29237788)

  • 1. Nucleic Acid Amplification Test Quantitation as Predictor of Toxin Presence in Clostridium difficile Infection.
    Crobach MJT; Duszenko N; Terveer EM; Verduin CM; Kuijper EJ
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29237788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.
    Pollock NR; Banz A; Chen X; Williams D; Xu H; Cuddemi CA; Cui AX; Perrotta M; Alhassan E; Riou B; Lantz A; Miller MA; Kelly CP
    Clin Infect Dis; 2019 Jan; 68(1):78-86. PubMed ID: 29788296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can a toxin gene NAAT be used to predict toxin EIA and the severity of
    Garvey MI; Bradley CW; Wilkinson MAC; Holden E
    Antimicrob Resist Infect Control; 2017; 6():127. PubMed ID: 29270290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and outcome of Clostridium difficile infection by toxin enzyme immunoassay and polymerase chain reaction in an island population.
    Kumar S; Pollok R; Muscat I; Planche T
    J Gastroenterol Hepatol; 2017 Feb; 32(2):415-419. PubMed ID: 27505006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 4 molecular assays as part of a 2-step algorithm for the detection of Clostridium difficile in stool specimens.
    Caulfield AJ; Bolster LaSalle CM; Chang YH; Grys TE
    Diagn Microbiol Infect Dis; 2018 May; 91(1):1-5. PubMed ID: 29428547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of Single-Molecule Array Assays for Detection of Clostridium difficile Toxins in Comparison to Conventional Laboratory Testing Algorithms.
    Banz A; Lantz A; Riou B; Foussadier A; Miller M; Davies K; Wilcox M
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29898996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.
    Bamber AI; Fitzsimmons K; Cunniffe JG; Beasor CC; Mackintosh CA; Hobbs G
    Br J Biomed Sci; 2012; 69(3):112-8. PubMed ID: 23057158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
    Erb S; Frei R; Strandén AM; Dangel M; Tschudin-Sutter S; Widmer AF
    Clin Microbiol Infect; 2015 Nov; 21(11):998.e9-998.e15. PubMed ID: 26232535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield.
    Deshpande A; Pasupuleti V; Patel P; Ajani G; Hall G; Hu B; Jain A; Rolston DD
    Clin Gastroenterol Hepatol; 2011 Aug; 9(8):665-669.e1. PubMed ID: 21635969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of
    Senok AC; Aldosari KM; Alowaisheq RA; Abid OA; Alsuhaibani KA; Khan MA; Somily AM
    Saudi J Gastroenterol; 2017; 23(4):259-262. PubMed ID: 28721981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in Stool.
    Song L; Zhao M; Duffy DC; Hansen J; Shields K; Wungjiranirun M; Chen X; Xu H; Leffler DA; Sambol SP; Gerding DN; Kelly CP; Pollock NR
    J Clin Microbiol; 2015 Oct; 53(10):3204-12. PubMed ID: 26202120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology.
    Sandlund J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Bishop JJ; Nolan N; Estis J; Todd J; Young S; Senchyna F; Banaei N
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30158195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing a Clostridium difficile testing algorithm and its effect on isolation duration and treatment initiation: a pre- and post-implementation study.
    Vogelzang EH; Lankelma JM; van Mansfeld R; van Prehn J; van Houdt R
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1071-1076. PubMed ID: 31970532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory Diagnosis of
    Chung HS; Park JS; Shin BM
    Ann Lab Med; 2019 May; 39(3):317-321. PubMed ID: 30623624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the use of laboratory tests for the diagnosis of Clostridium difficile infection and association with incidence rates in Quebec, Canada, 2010-2014.
    Bogaty C; Lévesque S; Garenc C; Frenette C; Bolduc D; Galarneau LA; Lalancette C; Loo V; Tremblay C; Trudeau M; Vachon J; Dionne M; Villeneuve J; Longtin J; Longtin Y;
    Am J Infect Control; 2017 Sep; 45(9):964-968. PubMed ID: 28549882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High proportion of false-positive Clostridium difficile enzyme immunoassays for toxin A and B in pediatric patients.
    Toltzis P; Nerandzic MM; Saade E; O'Riordan MA; Smathers S; Zaoutis T; Kim J; Donskey CJ
    Infect Control Hosp Epidemiol; 2012 Feb; 33(2):175-9. PubMed ID: 22227987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
    Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
    Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
    Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
    Humphries RM; Uslan DZ; Rubin Z
    J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Cançado GGL; Silva ROS; Nader AP; Lobato FCF; Vilela EG
    J Gastroenterol Hepatol; 2018 Feb; 33(2):393-396. PubMed ID: 28730697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.